Thomas Jefferson University-Sidney Kimmel Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.
Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.
Thomas Jefferson University-Sidney Kimmel Cancer Center has participated in 34 clinical trials with 16 currently active.
Therapeutic areas: Acute Myeloid Leukemia, B-cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia.
Sponsors: Prelude Therapeutics, enGene, Inc., Daiichi Sankyo.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Philadelphia
Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Thomas Jefferson University-Sidney Kimmel Cancer Center has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Thomas Jefferson University-Sidney Kimmel Cancer Center has 34 clinical trials on record, with 16 currently active. Their work covers Acute Myeloid Leukemia, B-cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia.
Thomas Jefferson University-Sidney Kimmel Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.